Literature DB >> 11555581

Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma.

R Masood1, J Cai, A Tulpule, T Zheng, A Hamilton, S Sharma, B M Espina, D L Smith, P S Gill.   

Abstract

Kaposi's sarcoma (KS) is the most common tumor associated with HIV-1 infection. Here, we report the expression, regulation, and biological effect of interleukin (IL)-8 in KS. AIDS-KS cell lines expressed higher levels of IL-8 than either human umbilical vein endothelial cells (HUVECs), human aortic smooth muscle (AoSM) cells or fibroblast cells (T1). The inflammatory cytokine IL-1beta up-regulated IL-8 expression in a time- and concentration-dependent manner in KS cell lines. IL-8 antisense oligonucleotides specifically reduced IL-8 mRNA and protein levels and inhibited KS cell growth in a dose-dependent manner. In addition, supernatant from a KS cell line induced the growth of HUVECs and angiogenesis in chicken chorioallantoic membrane assays, both of which were inhibited by IL-8 neutralizing antibody. Serum levels of IL-8 were also elevated in KS cases compared with matched controls. Modulation of IL-8 may thus be of therapeutic value in this disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11555581

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  17 in total

1.  Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor.

Authors:  Rizwan Masood; Ethel Cesarman; D Lynne Smith; Parkash S Gill; Ornella Flore
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

2.  CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation.

Authors:  Seema Singh; Sheng Wu; Michelle Varney; Ajay P Singh; Rakesh K Singh
Journal:  Microvasc Res       Date:  2011-07-01       Impact factor: 3.514

Review 3.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

4.  Opposing roles of RNA receptors TLR3 and RIG-I in the inflammatory response to double-stranded RNA in a Kaposi's sarcoma cell line.

Authors:  April J Livengood; Christina C N Wu; Dennis A Carson
Journal:  Cell Immunol       Date:  2007-12-26       Impact factor: 4.868

5.  Engagement of toll-like receptor 3 induces vascular endothelial growth factor and interleukin-8 in human rheumatoid synovial fibroblasts.

Authors:  Su-Jin Moon; Mi-Kyung Park; Hye-Jwa Oh; Seon-Yeong Lee; Seung-Ki Kwok; Mi-La Cho; Ji Hyeon Ju; Kyung-Su Park; Ho-Youn Kim; Sung-Hwan Park
Journal:  Korean J Intern Med       Date:  2010-11-27       Impact factor: 2.884

6.  Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.

Authors:  Meichi Hsu; Shih-Yi Wu; Shih-Shin Chang; Ih-Jen Su; Ching-Hwa Tsai; Siao-Jing Lai; Ai-Li Shiau; Kenzo Takada; Yao Chang
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

7.  Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo.

Authors:  Laura Rosanò; Francesca Spinella; Valeriana Di Castro; Maria Rita Nicotra; Adriana Albini; Pier Giorgio Natali; Anna Bagnato
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

8.  Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer.

Authors:  Claudia Rubie; Vilma Oliveira Frick; Sandra Pfeil; Mathias Wagner; Otto Kollmar; Berit Kopp; Stefan Graber; Bettina M Rau; Martin K Schilling
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

9.  Induction of a potential paracrine angiogenic loop between human THP-1 macrophages and human microvascular endothelial cells during Bartonella henselae infection.

Authors:  Sandra I Resto-Ruiz; Michael Schmiederer; Debra Sweger; Catherine Newton; Thomas W Klein; Herman Friedman; Burt E Anderson
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

10.  Well-defined degradable cationic polylactide as nanocarrier for the delivery of siRNA to silence angiogenesis in prostate cancer.

Authors:  Chih-Kuang Chen; Wing-Cheung Law; Ravikumar Aalinkeel; Bindukumar Nair; Atcha Kopwitthaya; Supriya D Mahajan; Jessica L Reynolds; Jiong Zou; Stanley A Schwartz; Paras N Prasad; Chong Cheng
Journal:  Adv Healthc Mater       Date:  2012-07-26       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.